Yuyu Pharma Inc (000225) — Cash Flow Reinvestment Rate
Yuyu Pharma Inc (000225) has a Cash Flow Reinvestment Rate of 1.24x as of March 2026, reinvesting ₩3.66 Billion (capex ₩3.19 Billion plus investments ₩-468.91 Million) from operating cash flow of ₩2.95 Billion. See Yuyu Pharma Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Yuyu Pharma Inc Cash Flow Reinvestment Rate (2014–2025)
Historical reinvestment intensity for Yuyu Pharma Inc across 9 annual periods. For the full cash flow conversion analysis, see 000225 cash generation efficiency.
Annual Cash Flow Reinvestment Rate for Yuyu Pharma Inc (2014–2025)
Year-by-year capital reinvestment analysis for Yuyu Pharma Inc. See Yuyu Pharma Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.84x | ₩13.38 Billion | ₩15.88 Billion | ₩8.45 Billion | ▲ +126.2% |
| 2024 | 0.37x | ₩9.30 Billion | ₩24.95 Billion | ₩7.30 Billion | ▼ -97.9% |
| 2023 | 17.93x | ₩7.55 Billion | ₩420.86 Million | ₩5.11 Billion | ▲ +1205.4% |
| 2021 | 1.37x | ₩6.19 Billion | ₩4.51 Billion | ₩6.07 Billion | ▲ +108.6% |
| 2019 | 0.66x | ₩8.68 Billion | ₩13.19 Billion | ₩8.06 Billion | ▼ -59.2% |
| 2018 | 1.61x | ₩9.87 Billion | ₩6.11 Billion | ₩9.76 Billion | ▼ -83.4% |
| 2017 | 9.74x | ₩5.46 Billion | ₩561.35 Million | ₩5.19 Billion | ▲ +2433.5% |
| 2016 | 0.38x | ₩3.77 Billion | ₩9.82 Billion | ₩2.32 Billion | ▼ -80.8% |
| 2014 | 2.00x | ₩2.73 Billion | ₩1.36 Billion | ₩404.37 Million | — |